MEDNAX (MD) Tops Q3 EPS by 4c

MEDNAX (NYSE: MD) reported Q3 EPS of $0.46, $0.04 better than the analyst estimate of $0.42. Revenue for the quarter came in at $493 million versus the consensus estimate of $480.89 million.

For earnings history and earnings-related data on MEDNAX (MD) click here.

You May Also Be Interested In

• Are we witnessing a fundamental or speculative rally in the S&P 500?
• C3.ai (AI) Tops Q4 EPS by 5c, Beats on Revenue; Offers FY27 Revenue Guidance
• Pediatrix Medical Group Announces Publication of New Research Addressing Urgent Questions in Neonatology